Biogen, is a biotechnology company. The sales of its newly released Alzheimer's drug (Aduhelm) has rapidly increased to USD 900 milion, while its total production and marketing costs are USD 200 million. Biogen's multiple sclerosis drug (Tecfidera) is facing strong competition from competitors generic drugs, which caused its sales to drop slightly What product life cycle stages are these bo drug 1 points Spr in? O a. Aduhelm is in introduction stage and Tecfidera in mature stage O b. Aduhelm is in product development stage and Tecfidera in mature stage c. Both Aduhelm and Tecfidera are in mature stage O d. Aduhelm is in growth stage and Tecfidera in mature stage Question REN
